D-PATH Dermatopathology Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • D-PATH Dermatopathology's estimated annual revenue is currently $1.7M per year.(i)
  • D-PATH Dermatopathology's estimated revenue per employee is $155,000

Employee Data

  • D-PATH Dermatopathology has 11 Employees.(i)
  • D-PATH Dermatopathology grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M110%N/AN/A
#2
$5M3214%N/AN/A
#3
$3.6M235%N/AN/A
#4
$1.1M7-22%N/AN/A
#5
$1.7M110%N/AN/A
#6
$0.8M50%N/AN/A
#7
$6M3950%N/AN/A
#8
$0.9M60%N/AN/A
#9
$4.8M31-6%N/AN/A
#10
$1.9M120%N/AN/A
Add Company

What Is D-PATH Dermatopathology?

Founded in 2008, D-PATH is one of the only physician owned laboratories in the United States dedicated solely to the practice of dermatopathology.  D-PATH is committed to delivering the highest quality dermatopathology diagnoses, made exclusively by one of our board-certified dermatopathologists. D-PATH Dermatopathology offers a comprehensive test menu to their dermatology clients and patients. We strive to deliver not only the broadest range of services but also the highest quality test offering. Our commitment to quality and service is delivered in a number of ways. Diagnostic Excellence: 100% board-certified dermatopathology staff Exclusive focus on dermatopathology Outside expert review of all unusual or challenging cases Clear and concise diagnoses Industry Leading Service: 1-3 day turnaround time for results Comprehensive managed care coverage Photomicrographs available on all reports Immediate telephone access to dermatopathologists Access to results via EMR interfaces Nationwide courier network Hematopathology: D-PATH dermatopathologists have access to an in-house team of experts in hematopathology. This team of board-certified experts has the latest technology to provide expert consultation in these critical patient cases. Histology & Special Stains: D-PATH’s core business is centered on routine histologic diagnosis of tissue biopsies. We are equipped with the latest technology and processes including a comprehensive menu of special stains to address all dermatologic conditions. Immunofluorescence (IF): The accurate diagnosis of bullous and other immune diseases of the skin requires evaluation by immunofluorescence. If you require IF evaluation, please contact our client service team so they can ensure you have the appropriate collection kits. Immunohistochemistry: A comprehensive menu IHC markers and special stains are offered. These include such important stains as CD34, Cytokeratin, Facor XIIIa and the Pan-melanocyte cocktail.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M1110%N/A
#2
$1M1110%N/A
#3
$1.7M1110%N/A
#4
$1M110%N/A
#5
N/A1220%N/A